The lack of typical cGAS-STING-induced type I interferon expression in response to SRA737 + low dose HU treatment in vivo [17] also suggested that this pathway was not responsible for the pro-inflammatory chemokine expression observed in two syngeneic melanoma models with this treatment (Figure 2B). This evidence concerns the gene CGAS and melanoma.